FDA Approves New BARDA-Supported
Smallpox Antiviral Drug
The FDA’s approval of TPOXX® (tecovirimat) — the first and only approved antiviral treatment for smallpox — marks a milestone for biosecurity and a triumph against one of the most deadly diseases in history. The approval also serves as an exemplary model of government working collaboratively with its interagency partners and industry to meet a national biodefense need.
El gobernador McKee presenta una enmienda presupuestaria de $1,3 millones para apoyar a las empresas afectadas por el puente de Washington PROVIDENCE,...
30,000 in RI Applied for 2,500 Charter School Seats Tens of thousands of students are seeking to attend Rhode Island’s public charter schools. There...